Biocon Fact Sheet, Biocon Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Biocon Fact Sheet    (BICN)


LIVE on April 23rd: Has Covid impacted India's long-term growth potential?


Here is the latest financial fact sheet of Biocon. For more details, see the Biocon quarterly results and Biocon share price and chart. For a sector overview, read our pharmaceuticals sector report.

BIOCON Price History

Price Rs 401.1
Mkt Cap Rs m 240,660
Vol '000 166.8
P/E X 33.1
P/CF X 16.6
EPS (TTM) Rs 12.1
% ch % -1.3
No. of shares m 600.00
% ch week % -0.7
% ch 1-mth % 1.3
% ch 12-mth % 12.1
52 week H/L Rs 487.7/320.9
(As on Apr 20, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

BIOCON Financials

No. of Mths
Year Ending
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
5-Yr Chart
Click to enlarge
BIOCON  EQUITY SHARE DATA
High Rs5544961,1621,188707 
Low Rs407397483305554 
Sales per share (Unadj.) Rs154.5167.4194.668.791.9 
Earnings per share (Unadj.) Rs24.930.534.47.616.7 
Diluted earnings per shareRs8.310.211.57.616.7 
Cash flow per share (Unadj.) Rs35.942.948.314.024.2 
Dividends per share (Unadj.) Rs5.005.001.001.001.00 
Adj. dividends per shareRs1.671.670.331.001.00 
Dividend yield (eoy) %1.01.10.10.10.2 
Book value per share (Unadj.) Rs163.1201.7241.986.3101.6 
Adj. book value per shareRs54.467.280.686.3101.6 
Shares outstanding (eoy) m200.00200.00200.00600.00600.00 
Bonus/Rights/Conversions  ---IS- 
Price / Sales ratio x3.12.74.210.96.9 
Avg P/E ratio x19.314.623.998.937.7 
P/CF ratio (eoy) x13.410.417.053.426.1 
Price / Book Value ratio x2.92.23.48.66.2 
Dividend payout %20.116.42.913.26.0 
Avg Mkt Cap Rs m96,08089,220164,440447,900378,330 
No. of employees `0007.54.49.26.16.1 
Total wages/salary Rs m5,3346,1017,4709,31111,653 
Avg. sales/employee Rs Th4,119.77,581.94,213.96,705.88,994.3 
Avg. wages/employee Rs Th711.21,381.9809.01,514.21,900.7 
Avg. net profit/employee Rs Th663.21,379.6745.2736.91,635.3 
BIOCON  INCOME DATA
Net Sales Rs m30,89833,47438,91141,23455,144 
Other income Rs m5317921,5712,0621,444 
Total revenues Rs m31,42934,26640,48243,29656,588 
Gross profit Rs m6,9587,6789,7958,29115,883 
Depreciation Rs m2,2102,4872,7723,8514,478 
Interest Rs m89293260615709 
Profit before tax Rs m5,1905,6908,3345,88712,140 
Minority Interest Rs m-3102171632139 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m1,0511,606000 
Tax Rs m9571,4221,6161,5692,123 
Profit after tax Rs m4,9746,0916,8814,53110,026 
Gross profit margin %22.522.925.220.128.8 
Effective tax rate %18.425.019.426.717.5 
Net profit margin %16.118.217.711.018.2 
BIOCON  BALANCE SHEET DATA
Current assets Rs m24,75039,70940,47741,48648,228 
Current liabilities Rs m15,97416,65716,78321,41330,376 
Net working cap to sales %28.468.960.948.732.4 
Current ratio x1.52.42.41.91.6 
Inventory Days Days5659606468 
Debtors Days Days8178839486 
Net fixed assets Rs m34,16940,14645,07350,66164,130 
Share capital Rs m1,0001,0001,0003,0003,000 
"Free" reserves Rs m31,62239,33847,37748,80857,980 
Net worth Rs m32,62240,33848,37751,80860,980 
Long term debt Rs m7,67120,72421,08218,08315,766 
Total assets Rs m63,31984,58193,94299,897121,924 
Interest coverage x59.320.433.110.618.1 
Debt to equity ratio x0.20.50.40.30.3 
Sales to assets ratio x0.50.40.40.40.5 
Return on assets %8.07.57.65.28.8 
Return on equity %15.215.114.28.716.4 
Return on capital %14.912.812.69.616.8 
Exports to sales %33.532.033.429.228.1 
Imports to sales %19.721.220.317.818.9 
Exports (fob) Rs m10,33910,71712,98812,05815,506 
Imports (cif) Rs m6,1027,1057,8997,34810,399 
Fx inflow Rs m10,99311,78912,98812,05815,506 
Fx outflow Rs m7,3718,4457,8997,34810,399 
Net fx Rs m3,6223,3445,0894,7105,107 
BIOCON  CASH FLOW
From Operations Rs m 2,107 3,706 6,400 6,621 11,546 
From Investments Rs m -5,087 -11,417 -4,985 -6,840 -7,138 
From Financial Activity Rs m 1,862 10,676 -1,775 -2,397 -2,417 
Net Cashflow Rs m -1,118 3,000 -473 -2,612 2,103 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 40.4%
Foreign collaborators 20.6%
Indian inst/Mut Fund 8.4%
FIIs 10.7%
ADR/GDR 0.0%
Free float 19.9%
Shareholders 109,995
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF 20th KM, Hosur Road, Electronic City, Bangalore - 560 100
E-MAIL kiran.kumar@biocon.com WEB www.biocon.com
TELEPHONE (080) 2808 2037 FAX (080) 2852 3423
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Karvy Computershare, 17-24, Vithalrao Nagar, Madhapur, Hyderabad-81
AUDITOR S. R. Batliboi & Assoc.
CHM: Kiran Mazumdar Shaw (MD) COMP SEC: Kiran Kumar YEAR OF INC: 1978 BSE CODE: 532523 FV (Rs): 5 DIV YIELD (%): 0.2

More Pharmaceuticals Company Fact Sheets:   SUVEN LIFE SCIENCES  PROCTER & GAMBLE HEALTH  JUBILANT PHARMOVA   VENUS REMEDIES  PIRAMAL ENTERPRISES  

Compare BIOCON With:   SUVEN LIFE SCIENCES  PROCTER & GAMBLE HEALTH  JUBILANT PHARMOVA   VENUS REMEDIES  PIRAMAL ENTERPRISES  

Compare BIOCON With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  




Today's Market

Sensex Ends 244 Points Lower, Nifty Ends Below 14,300; UltraTech Cement & HCL Tech Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Views on news

BIOCON Announces Quarterly Results (3QFY21); Net Profit Down 19.7% (Quarterly Result Update)

Jan 25, 2021 | Updated on Jan 25, 2021

For the quarter ended December 2020, BIOCON has posted a net profit of Rs 2 bn (down 19.7% YoY). Sales on the other hand came in at Rs 19 bn (up 5.9% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (2QFY21); Net Profit Down 23.9% (Quarterly Result Update)

Oct 29, 2020 | Updated on Oct 29, 2020

For the quarter ended September 2020, BIOCON has posted a net profit of Rs 2 bn (down 23.9% YoY). Sales on the other hand came in at Rs 17 bn (up 11.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games? (The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

A Stock with 700% Return Potential Comes with Additional Payoffs (Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

Top 3 Nifty ETFs to Buy Now (Fast Profits Daily)

Apr 20, 2021

In this video I tell you the three Nifty ETFs I think are the best.

11x Bankruptcy to Bluechip Stock: A Rare India Revival Story (Profit Hunter)

Apr 16, 2021

There is no stopping this 11-bagger stock from significant upside.

Why Did the Market Crash on Monday? (Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TRACK BIOCON

MORE ON BIOCON

BIOCON - IPCA LABS COMPARISON

COMPARE BIOCON WITH

MARKET STATS